Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of coumarin derivative with 1,2,4-oxadiazole-structural fragment and its application

A technology of coumarin derivatives and structural fragments, which is applied in the field of medicine and can solve problems such as poor therapeutic effect

Inactive Publication Date: 2019-02-15
UNIV OF JINAN
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the therapeutic effects of these AchE inhibitors are not good. For example, tacrine needs to be taken 4 times a day and has potential severe liver toxicity. The other three drugs for improving AD symptoms can only provide limited relief or stabilization in specific stages of disease development. disease with serious side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of coumarin derivative with 1,2,4-oxadiazole-structural fragment and its application
  • A kind of coumarin derivative with 1,2,4-oxadiazole-structural fragment and its application
  • A kind of coumarin derivative with 1,2,4-oxadiazole-structural fragment and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Embodiment 1: the preparation of formula 3 compound

[0028]

[0029] Dissolve 880 mg of powdered 7-hydroxy-4-methylcoumarin (formula 1) in 50 ml of acetone, add 828 mg of potassium carbonate, stir for 0.5 h, then add 1.5 g of p-cyanobenzyl bromide (formula 2), 83 mg of potassium iodide and 156 mg of tetrabutylammonium bromide, stirred at 50° C. for 5 h, the reaction was complete as detected by TLC, and the reaction solution was concentrated. Recrystallization from 50% ethanol gave 1.426 g of compound formula 3, a yellow solid, with a yield of 98%. 1 H NMR (400MHz, CDCl 3 )δ7.73(d, J=8.3Hz, 2H), 7.57(dd, J=11.6, 8.5Hz, 3H), 6.95(dd, J=8.8, 2.5Hz, 1H), 6.88(d, J=2.5 Hz,1H),6.18(s,1H),5.21(s,2H),2.43(s,3H).ESI-MS m / z:292.4[M+H]+.

Embodiment 2

[0030] Embodiment 2: the preparation of formula 4 compound

[0031]

[0032] Dissolve 582mg of the compound of formula 3 in 10ml of absolute ethanol, cool to 0°C in ice bath, add 751mg of triethylamine and 308mg of hydroxylamine hydrochloride, stir for 0.5h, then heat to reflux (80°C) overnight. Extracted with ethyl acetate (25ml*3), the combined organic layers were washed 3 times with saturated sodium chloride solution, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography to obtain 395 mg of the compound of formula 4 as a yellow solid with a yield of 85%. 1 H NMR (400MHz, CDCl 3 )δ7.88(d,J=8.4Hz,1H),7.69(d,J=8.4Hz,1H),7.58–7.47(m,3H),6.99–6.93(m,1H),6.90(d,J =2.3Hz,1H),6.17(d,J=1.2Hz,1H),5.28–5.15(m,2H),4.89(s,2H),2.43(s,3H).ESI-MS m / z:325.2 [M+H]+.

Embodiment 3

[0033]Embodiment 3: the preparation of general formula I compound

[0034]

[0035] Dissolve 0.5mmol of the compound of formula 5 in 5ml of dichloromethane, add 0.55mmol of N,N-diisopropylethylamine and 0.55mmol of 2-(7-azobenzotriazole)-tetramethyluronium hexafluorophosphate (HATU ), stirred at room temperature for 3h, and TLC detected that the reaction was complete. Add 0.5 mmol of the compound of formula 4 dissolved in dichloromethane to the above reaction solution, stir at room temperature for three hours, TLC detects that the reaction is complete, and concentrate the reaction solution. Extracted with ethyl acetate (15ml*3), the combined organic layer was washed 3 times with saturated sodium chloride solution, dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain a residue. The above residue was dissolved in 10 ml of ethanol, 4 mmol of anhydrous sodium acetate was added, and heated to reflux (80° C.) overnight, TLC detected that the reac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a coumarin derivative with a 1,2,4-oxadiazole-structure fragment and application of the coumarin derivative. The coumarin derivative has a general structure formula shown as follows: the formula is show in the description; the coumarin derivative has a novel structure and a synthesis route is simple and convenient; the yield is high and the safety is good. An experiment proves that the compound provided by the invention has certain inhibition activity on AchE (Acetylcholinesterase), so that the invention further relates to application of the derivative to preparation a medicine for preventing and / or treating cholinergic function decreasing correlated diseases, such as Alzheimer's disease (AD). The invention further provides a pharmaceutical composition for preventing and / or treating the AD; the pharmaceutical composition is prepared by taking a 1,2,4-oxadiazole-structure fragment derivative as an active component or a main active component and matching pharmaceutically acceptable auxiliary materials.

Description

technical field [0001] The invention relates to a coumarin derivative with 1,2,4-oxadiazole-structural fragment and application thereof, which belongs to the field of medicine. Background technique [0002] Alzheimer's disease (Alzheimer's Disease, AD) is a progressive and fatal neurodegenerative disease (Noroozian M.Alzheimer's disease: prototype of cognitive deterioration, valuable lessons to understand human cognition. Neurol. Clin., 2016, 34,69-131), there is no clinically effective drug for the cause. In developed countries, AD has become the fourth cause of death in the elderly after heart disease, malignant tumors, and stroke. At present, there are about 5 million AD patients in my country, ranking first in the world (Liao Cuihong. Nursing Review of Alzheimer's Patients. Modern Health, 2015, 25, 215-216). AD has become the main burden of the health care system, bringing painful mental and economic pressure to the society, patients and family members, and is a very s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D413/12C07D413/14A61K31/4245A61K31/4709A61K31/4439A61P25/28
CPCC07D413/12C07D413/14
Inventor 江成世宋佳丽张华张娟李家诚成志强
Owner UNIV OF JINAN